Cargando…

Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide–MHC Complexes for T-Cell Receptor Immunotherapy

T-cell receptor (TCR) immunotherapy uses T cells engineered with new TCRs to enable detection and killing of cancer cells. Efficacy of TCR immunotherapy depends on targeting antigenic peptides that are efficiently presented by the best-suited major histocompatibility complex (MHC) molecules of cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenz, Felix K.M., Ellinger, Christian, Kieback, Elisa, Wilde, Susanne, Lietz, Maria, Schendel, Dolores J., Uckert, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737719/ https://www.ncbi.nlm.nih.gov/pubmed/28950731 http://dx.doi.org/10.1089/hum.2017.122

Ejemplares similares

Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8(+) T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7
por: Lorenz, Felix K. M., et al.
Publicado: (2015)

Induction and isolation of tumor antigen-specific CD4+ T lymphocytes using sorting signal directed MHC class-II expression
por: Ellinger, Christian, et al.
Publicado: (2013)

MHC Multimer-Guided and Cell Culture-Independent Isolation of Functional T Cell Receptors from Single Cells Facilitates TCR Identification for Immunotherapy
por: Dössinger, Georg, et al.
Publicado: (2013)

MHC Class I Bound to an Immunodominant Theileria parva Epitope Demonstrates Unconventional Presentation to T Cell Receptors
por: Macdonald, Isabel K., et al.
Publicado: (2010)

Generation of tumor antigen-specific CD4+ and CD8+ T cells by simultaneous MHC-I and -II epitope presentation in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2014)

Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors
por: Mösch, Anja, et al.
Publicado: (2019)

Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
por: Davari, Kathrin, et al.
Publicado: (2021)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them
por: Wilde, Susanne, et al.
Publicado: (2012)

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
por: Schendel, Dolores J., et al.
Publicado: (2013)

Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy
por: Pachmayr, Ludwig O., et al.
Publicado: (2023)

Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use
por: Wisskirchen, Karin, et al.
Publicado: (2017)

Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2013)

Cross-priming induces immunodomination in the presence of viral MHC class I inhibition
por: Lauron, Elvin J., et al.
Publicado: (2018)

A novel Minimalist Cell-Free MHC Class II Antigen Processing System Identifies Immunodominant Epitopes
por: Hartman, Isamu Z., et al.
Publicado: (2010)

An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes
Publicado: (1988)

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells
por: Lichtenegger, Felix S., et al.
Publicado: (2012)

Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination
por: Si, Youhui, et al.
Publicado: (2020)

T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
por: Sailer, Nadja, et al.
Publicado: (2022)

T cell receptor alpha variable 12‐2 bias in the immunodominant response to Yellow fever virus
por: Bovay, Amandine, et al.
Publicado: (2017)

Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies
por: Raybould, Matthew I. J., et al.
Publicado: (2023)

Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedure
por: Wilde, Susanne, et al.
Publicado: (2012)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation
por: Bürdek, Maja, et al.
Publicado: (2010)

Fluctuations in T cell receptor and pMHC interactions regulate T cell activation
por: Egan, Joseph R., et al.
Publicado: (2022)

Mechanisms influencing the immunodominance of T cell determinants
Publicado: (1988)

Defining B Cell Immunodominance to Viruses
por: Angeletti, Davide, et al.
Publicado: (2017)

In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns
por: Lopes-Ribeiro, Ágata, et al.
Publicado: (2022)

Structure-based prediction of T cell receptor:peptide-MHC interactions
por: Bradley, Philip
Publicado: (2023)

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen
Publicado: (1993)

NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability
por: Sommermeyer, Daniel, et al.
Publicado: (2013)

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
por: Deng, Yalan, et al.
Publicado: (2021)

Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time
por: Aleksic, Milos, et al.
Publicado: (2010)

Exosomal cancer immunotherapy is independent of MHC molecules on exosomes
por: Hiltbrunner, Stefanie, et al.
Publicado: (2016)

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy
por: Mathan, Till S.M., et al.
Publicado: (2017)

The somatically generated portion of T cell receptor CDR3α contributes to the MHC allele specificity of the T cell receptor
por: Marrack, Philippa, et al.
Publicado: (2017)

Correlation of T cell receptor V beta gene family with MHC restriction
Publicado: (1987)

Conformational changes and flexibility in T-cell receptor recognition of peptide–MHC complexes
por: Armstrong, Kathryn M., et al.
Publicado: (2008)

The basis for limited specificity and MHC restriction in a T cell receptor interface
por: Piepenbrink, Kurt H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6a3qdtfoimiqhaejb08b1b1iqg